This week, a survey gives us insight into the sex lives of millennials, a study finds women engage in riskier sex on vacation, and advocates try another tactic for mandating condoms in porn.
One Utah program makes students choose to promise to uphold several flawed statements on abstinence. I would love to believe that the students would be brave enough to challenge what’s written on the page, but just in case, I decided to explain why some of the most outrageous statements just don’t make sense.
A group hopes to encourage affirmative consent by creating an app that asks partners to record each other saying “yes” before having sex—but it might just cause more problems than it solves.
This week, teens get health and sex information on the web, condom demonstrations are allowed in New York City public school health classes, and a British woman serves time for being too loud.
An FDA advisory panel recommended Thursday that the agency approve flibanserin, a drug that has often been called the female Viagra.
Amy Adele Hasinoff’s Sexting Panic: Rethinking Criminalization, Privacy, and Consent is a reasoned, if academic, look at the ways teens use social media and the Internet to flirt, seduce, and tease, often transmitting sexual images that are intended for private viewing.
This week, a survey shows many women are not taking precautions against STDs, Men’s Health determines the “sex-happiest” cities, and a Dutch designer designs a sex toy to hold human ashes.
Unlike what a recent Elle.com article suggests, I can’t think of anything with a sexier payoff than spending time discussing the logistics of mutual pleasure.
By respecting our daughter’s wishes when she asks us to stop tickling her, my husband and I are modeling other correct behavior as well: We’re establishing, early on, the need to give and obtain consent when it comes to control of one’s own body.
Some advocates are calling the Food and Drug Administration’s historical hesitation to approve a drug that would treat low sex drive in women sexist; others are saying the development of the medication itself is sexist. Who’s in the right?